These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 28790267)

  • 1. [A Case of Recurrent Colorectal Cancer with Bilateral Ovarian Metastases That Were Reduced with Regorafenib Therapy].
    Nakae S; Nogi Y; Arima J; Okamoto D; Urakawa N; Fujikawa M; Gon H; Takebe A; Shinzeki M; Tanaka K; Senzaki H
    Gan To Kagaku Ryoho; 2017 Jul; 44(7):607-610. PubMed ID: 28790267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Stevens-Johnson syndrome induced by regorafenib in a patient with progressive recurrent rectal carcinoma].
    Mihara Y; Yamaguchi K; Nakama T; Nakayama G; Kamei H; Ishibashi N; Uchida S; Akagi Y; Ogata Y
    Gan To Kagaku Ryoho; 2015 Feb; 42(2):233-6. PubMed ID: 25743146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of erythema multiforme induced by regorafenib therapy for metastatic colon cancer].
    Mii Y; Fukuoka E; Murata K; Otsubo D; Sawa H; Oka S; Iwatani Y; Kuroda D
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1841-3. PubMed ID: 25731348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Patient with Cavitated Pulmonary Metastases Treated with Regorafenib].
    Taniguchi M; Mori M; Sata N; Fujii H
    Gan To Kagaku Ryoho; 2016 Jun; 43(6):757-9. PubMed ID: 27306815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful Administration of Regorafenib to a Metastatic Colon Cancer Patient with Impaired Performance Status by Reducing the Initial Dose].
    Nishitai R; Manaka D; Kudo R; Mitsuoka E; Kanai S; Kanto S; Yoshino K; Hamasu SY; Konishi S; Yamashiro Y
    Gan To Kagaku Ryoho; 2015 Jul; 42(7):871-3. PubMed ID: 26197753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Case of Advanced Colon Cancer with Long-Term and Re-Administration of Regorafenib].
    Funakoshi T; Kato T; Kuratani Y; Yamada K; Kenno S; Shibaki T; Yanagida N; Inagaki M; Ikeue S; Akabane H; Nakano S
    Gan To Kagaku Ryoho; 2016 May; 43(5):633-5. PubMed ID: 27210098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiological complete response with regorafenib for multiple lung metastases of ascending colon cancer: a case report.
    Kikuchi K; Ogawa M; Sasaki A
    J Med Case Rep; 2024 Feb; 18(1):45. PubMed ID: 38321556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of recurrent duodenal gastrointestinal stromal tumor resistant to imatinib and sunitinib, successfully treated with regorafenib].
    Takeda Y; Nakahira S; Katsura Y; Ohmura Y; Kusama H; Kuroda Y; Goto T; Hashimoto T; Kimura K; Matsushita K; Sato Y; Morimoto Y; Ishida T; Nitta K; Kagawa Y; Okishiro M; Takeno A; Sakisaka H; Taniguchi H; Egawa C; Ohzono K; Nakatsuka S; Kato T; Tamura S
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1545-7. PubMed ID: 25731247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case of Metastatic Lung Cancer from Colon Cancer with a Long Partial Response with Regorafenib Treatment].
    Iseki Y; Yashiro M; Shibutani M; Nagahara H; Maeda K; Matsutani S; Tamura T; Ohira G; Yamazoe S; Kimura K; Toyokawa T; Amano R; Tanaka H; Muguruma K; Hirakawa K; Ohira M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2338-2340. PubMed ID: 28133314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two Cases of the Significant Liver Damage by Regorafenib].
    Machida T; Yoshida M; Saiga H; Koide T; Matsumoto A; Wada T; Tanaka H; Harada N; Mitsutsuji M; Samizo M
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1600-1602. PubMed ID: 38303354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Case of Unresectable Recurrent Colorectal Cancer with Regorafenib Treatment and Long-Term Survival].
    Maruo H; Sato S; Nakamura T; Sekimori K; Obayashi M; Hayashi Y; Ishimatsu H; Shoji T; Hirayama K; Yamazaki M
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):1670-1672. PubMed ID: 35046292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of Administration Technique of Regorafenib in Our Center].
    Matsuda C; Danno K; Miyazaki S; Fujitani K; Kubota M; Motoori M; Nakatsuka R; Nishimura M; Kitagawa A; Takagi M; Iwase K
    Gan To Kagaku Ryoho; 2017 Jan; 44(1):47-51. PubMed ID: 28174379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tolerability and efficacy of regorafenib in patients with unresectable metastatic colorectal cancer].
    Tanaka A; Sadahiro S; Suzuki T; Okada K; Saito G
    Gan To Kagaku Ryoho; 2014 Oct; 41(10):1231-6. PubMed ID: 25335705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: implications for clinical management.
    Del Prete M; Giampieri R; Loupakis F; Prochilo T; Salvatore L; Faloppi L; Bianconi M; Bittoni A; Aprile G; Zaniboni A; Falcone A; Scartozzi M; Cascinu S
    Oncotarget; 2015 Oct; 6(32):33982-92. PubMed ID: 26334693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib.
    Wong AL; Lim JS; Sinha A; Gopinathan A; Lim R; Tan CS; Soh T; Venkatesh S; Titin C; Sapari NS; Lee SC; Yong WP; Tan DS; Pang B; Wang TT; Zee YK; Soong R; Trnkova Z; Lathia C; Thiery JP; Wilhelm S; Jeffers M; Goh BC
    J Transl Med; 2015 Feb; 13():57. PubMed ID: 25889309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal perforation during regorafenib administration in a case with hepatic metastases of colon cancer.
    Ogata K; Takamori H; Umezaki N; Yagi T; Ogawa K; Ozaki N; Hayashi H; Tanaka H; Ikuta Y; Doi K
    J Chemother; 2017 Oct; 29(5):314-316. PubMed ID: 27438692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Liver Failure Due to Regorafenib May Be Caused by Impaired Liver Blood Flow: A Case Report.
    Akamine T; Ando K; Oki E; Saeki H; Nakashima Y; Imamura YU; Ohgaki K; Maehara Y
    Anticancer Res; 2015 Jul; 35(7):4037-41. PubMed ID: 26124352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute liver failure and seizures as a consequence of regorafenib exposure in advanced rectal cancer.
    Raissouni S; Quraishi Z; Al-Ghamdi M; Monzon J; Tang P; Vickers MM
    BMC Res Notes; 2015 Oct; 8():538. PubMed ID: 26438070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regorafenib: from bench to bedside in colorectal cancer.
    Shahda S; Saif MW
    Expert Rev Clin Pharmacol; 2013 May; 6(3):243-8. PubMed ID: 23656338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel germline mutation of PDGFR-β might be associated with clinical response of colorectal cancer to regorafenib.
    Rechsteiner M; Wild P; Kiessling MK; Bohnert A; Zhong Q; Stahel RA; Moch H; Curioni-Fontecedro A
    Ann Oncol; 2015 Jan; 26(1):246-248. PubMed ID: 25336117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.